Senescence marker p16INK4a expression in patients with multiple sclerosis
Open Access
- 11 February 2024
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 84, 105498
Abstract
No abstract availableKeywords
Funding Information
- National MS Society
- University of California, San Diego
This publication has 35 references indexed in Scilit:
- Ageing and multiple sclerosisThe Lancet Neurology, 2022
- Rejuvenation of the aged brain immune cell landscape in mice through p16-positive senescent cell clearanceNature Communications, 2022
- Pharmacological Depletion of Microglia Leads to a Dose-Dependent Reduction in Inflammation and Senescence in the Aged Murine BrainNeuroscience, 2022
- What telomeres teach us about MSMultiple Sclerosis and Related Disorders, 2021
- Leukocyte Telomere Length in Patients with Multiple Sclerosis and Its Association with Clinical PhenotypesMolecular Neurobiology, 2021
- Telomere Length Is Associated with Disability Progression in Multiple SclerosisAnnals of Neurology, 2019
- Naturally occurring p16Ink4a-positive cells shorten healthy lifespanNature, 2016
- Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs?Trends in Endocrinology & Metabolism, 2015
- Clearance of p16Ink4a-positive senescent cells delays ageing-associated disordersNature, 2011
- Telomeres, immune aging and autoimmunityExperimental Gerontology, 2006